MNS1: Regulating Meiosis-Specific Nuclear Structure (G55329)

Target Name: MNS1

NCBI ID: G55329

MNS1

MNS1: Regulating Meiosis-Specific Nuclear Structure

MNS1 (Meiosis-Specific Nuclear Structural 1) is a protein that plays a crucial role in the process of meiosis, which is a type of cell division that leads to the formation of haploid cells. Meiosis is important for the development and maintenance of tissue stem cells, and MNS1 is involved in the regulation of meiosis-specific nuclear structure.

MNS1 was first identified in 2001 using DNA sequencing techniques. It is a 22 kDa protein that is expressed in a variety of tissues, including muscle, liver, and brain. MNS1 is primarily localized to the nuclei of cells during meiosis, and it is involved in the maintenance of the nuclear structure during this process.

One of the key functions of MNS1 is its role in the regulation of meiosis-specific nuclear structure. MNS1 helps to ensure that the nuclear structure remains stable and undisturbed during meiosis. This is important for the proper functioning of the meiosis-specific nuclear structure, as it allows the chromosomes to be correctly sorted and divided during meiosis.

MNS1 is also involved in the regulation of the expression of other genes during meiosis. For example, MNS1 has been shown to help to repress the expression of the gene PMO7 (Protamine 7), which encodes a protein involved in the formation of the nuclear envelope. This helps to maintain the stability of the nuclear structure and prevent the formation of foreign particles within the cell.

In addition to its role in meiosis, MNS1 has also been shown to be involved in the regulation of cell cycle progression. It helps to ensure that the cell cycle proceeds in a orderly and accurate manner, which is important for the development and maintenance of tissues.

MNS1 has also been shown to play a role in the regulation of DNA replication. It is involved in the formation of a protein complex that helps to ensure the accurate duplication of DNA during the cell cycle. This helps to ensure that each new cell that is produced has an accurate copy of the genetic material.

MNS1 has also been shown to be involved in the regulation of gene expression during development. For example, it has been shown to help to repress the expression of the gene Par (Parathyroid Hormone Receptor), which encodes a protein involved in the regulation of calcium levels within the body. This helps to ensure that the cells of the developing body maintain the correct levels of calcium, which is important for the proper functioning of many tissues.

In conclusion, MNS1 is a protein that plays a crucial role in the process of meiosis. It is involved in the regulation of meiosis-specific nuclear structure, the expression of other genes during meiosis, cell cycle progression, DNA replication, and gene expression during development. As a result, MNS1 may be a valuable drug target or biomarker for the development of new treatments for a variety of diseases.

Protein Name: Meiosis Specific Nuclear Structural 1

Functions: May play a role in the control of meiotic division and germ cell differentiation through regulation of pairing and recombination during meiosis. Required for sperm flagella assembly (By similarity). May play a role in the assembly and function of the outer dynein arm-docking complex (ODA-DC). ODA-DC mediates outer dynein arms (ODA) binding onto the axonemal doublet microtubules (PubMed:30148830)

The "MNS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MNS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets